Загрузка...
Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patients treated with omalizumab and review the published i...
Сохранить в:
| Опубликовано в: : | Front Immunol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8007859/ https://ncbi.nlm.nih.gov/pubmed/33796115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652973 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|